Lunger John Insider Trades

Insider Trading History

Track insider trading activity for Lunger John. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Chief Patient Supply Officer
Holding Value $78.2k 1,612,032 shares
Last Trade
Feb 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$934k 1,612,032 shares
$0.58
$0.05
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Chief Patient Supply Officer
Holding Value $364 7,510 shares
Last Trade
Jan 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.24k 5,584 shares
$0.58
$0.05
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Chief Patient Supply Officer
Holding Value $667 13,756 shares
Last Trade
Jan 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.59k 9,803 shares
$0.57
$0.05
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Chief Patient Supply Officer
Holding Value $370 7,623 shares
Last Trade
Jan 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.75k 9,739 shares
$0.59
$0.05
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Chief Patient Supply Officer
Holding Value $922 19,015 shares
Last Trade
Jan 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.1k 18,114 shares
$0.67
$0.05
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Chief Patient Supply Officer
Holding Value $341 7,023 shares
Last Trade
Jan 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.32k 4,681 shares
$0.71
$0.05
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Chief Patient Supply Officer
Holding Value $123k 2,544,432 shares
Last Trade
Jan 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.09M 2,544,432 shares
$0.82
$0.05
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Chief Patient Supply Officer
Holding Value $382 7,874 shares
Last Trade
Jan 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.44k 5,220 shares
$0.85
$0.05
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Chief Patient Supply Officer
Holding Value $296 6,104 shares
Last Trade
Jan 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.37k 4,009 shares
$0.84
$0.05
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc ADAP
Chief Patient Supply Officer
Holding Value $229 4,718 shares
Last Trade
Aug 01, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.82k 3,096 shares
$0.91
$0.05
Genocea Biosciences
Genocea Biosciences GNCA
Director
Holding Value $3 30,000 shares
Last Trade
Mar 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.8k 30,000 shares
$1.06
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up